Stock Fundamentals

Company Information

Company Name
Zentalis Pharmaceuticals Llc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US98943L1070
CIK: 0001725160
CUSIP: 98943L107
Currency: USD
Full Time Employees: 106
Phone: 858 263 4333
Fiscal Year End: December
IPO Date: Apr 03, 2020
Description:

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.

Address:

10275 Science Center Dr., San Diego, CA, United States, 92121

Directors & Officers

Name Title Year Born
Ms. Julie M. Eastland M.B.A. CEO, President & Director 1964
Mr. James B. Bucher J.D. Chief Legal Officer & Corporate Secretary 1966
Dr. Ingmar Bruns M.D., Ph.D. Chief Medical Officer 1975
Mr. Vincent A. Vultaggio SVP of Finance & Principal Accounting Officer 1984
Mr. Robert J. DiVasto P.E. Chief Technical Officer 1956
Ms. Wendy Chang Chief People Officer NA
Mr. Haibo Wang Chief Business Officer NA
Mr. Rajesh Israni Executive VP of Regulatory Affairs & Medical Writing NA
Mr. Henry Gu Senior VP & Head of Intellectual Property NA
Ms. Sarah Kelly Senior Vice President of Commercial Strategy NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 10, 2026 Vincent Vultaggio N/A Sale 6.89K $2.42 $16.68K
Feb 09, 2026 Ingmar Bruns N/A Sale 335.00 $2.39 $800.65
Feb 09, 2026 Vincent Vultaggio N/A Sale 3.38K $2.39 $8.08K
Feb 06, 2026 Ingmar Bruns N/A Sale 2.96K $2.43 $7.20K
Feb 06, 2026 Vincent Vultaggio N/A Sale 29.95K $2.43 $72.78K
Feb 03, 2026 Vincent Vultaggio N/A Sale 556.00 $2.52 $1.40K
Feb 02, 2026 Vincent Vultaggio N/A Sale 2.54K $2.55 $6.48K
Dec 31, 2025 Group Walters N/A Purchase 6.46M $1.20 $7.75M
Dec 15, 2025 Matrix Capital Management Comp N/A Sale 7.50M $1.33 $9.98M
Apr 30, 2025 Scott Dunseth Myers N/A Purchase 21.00K $1.40 $29.40K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Squadron Capital Management LLC 4.03M Mar 31, 2026 5.66% $3.46 0.00%
5AM Venture Management, LLC 3.95M Mar 31, 2026 5.55% $2.56 0.00%
Two Sigma Investments LLC 2.96M Mar 31, 2026 4.15% $0.01 100.93%
Vanguard Group Inc 2.86M Dec 31, 2025 4.01% $0.00 -1.68%
Acadian Asset Management LLC 2.85M Mar 31, 2026 4.00% $0.01 0.00%
Vanguard Capital Management, LLC 2.31M Mar 31, 2026 3.25% $0.00 0.00%
Renaissance Technologies Corp 1.94M Mar 31, 2026 2.72% $0.01 -32.79%
Citadel Advisors Llc 1.73M Mar 31, 2026 2.43% $0.00 -11.82%
D. E. Shaw & Co LP 1.48M Mar 31, 2026 2.08% $0.00 -10.62%
Two Sigma Advisers, LLC 1.48M Dec 31, 2025 2.08% $0.00 1.53%
Opaleye Management Inc 1.41M Mar 31, 2026 1.98% $0.44 0.84%
Decheng Capital LLC 1.32M Mar 31, 2026 1.86% $0.47 0.00%
Millennium Management LLC 1.29M Mar 31, 2026 1.81% $0.00 91.62%
BlackRock Inc 1.27M Mar 31, 2026 1.78% $0.00 1.59%
Ishara Investments LP 1.23M Mar 31, 2026 1.73% $2.72 -6.82%
Bank of America Corp 1.13M Mar 31, 2026 1.59% $0.00 -17.18%
PRIMECAP Management Company 957.42K Mar 31, 2026 1.34% $0.00 0.00%
Pfizer Inc 953.83K Mar 31, 2026 1.34% $0.84 0.00%
Connor Clark & Lunn Inv Mgmt Ltd 792.00K Mar 31, 2026 1.11% $0.00 0.63%
Qube Research & Technologies 637.12K Mar 31, 2026 0.90% $0.00 3,546.71%

Shares Statistics

Shares Outstanding: 71.19M
Shares Float: 48.97M
% Insiders: 2,244.20%
% Institutions: 6,206.30%
Short % Float: 8.83%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.89M 2.66% ▲ 11.59% Apr 30, 2026
2 Franklin Biotechnology Discv A(acc)USD 759.26K 1.07% ▲ 0.00% Apr 30, 2026
3 PRIMECAP Odyssey Aggressive Growth 676.40K 0.95% ▲ 0.00% Mar 31, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 577.89K 0.81% ▲ 6.28% Apr 30, 2026
5 Franklin Biotechnology Discovery A 440.04K 0.62% ▲ 0.00% Apr 30, 2026
6 Fidelity Extended Market Index 277.83K 0.39% ▼ 0.36% Apr 30, 2026
7 Vanguard US Opportunities Ins USD Acc 261.92K 0.37% ▲ 0.00% Mar 31, 2026
8 Fidelity Enhanced Small Cap Core ETF 256.77K 0.36% ▲ 0.25% May 29, 2026
9 Vanguard Strategic Small-Cap Equity Inv 209.33K 0.29% ▲ 0.00% Mar 31, 2026
10 iShares Micro-Cap ETF 162.08K 0.23% ▲ 0.00% May 29, 2026

Valuation Metrics

Enterprise Value: $90.91M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $266.95M
EBITDA: $-141.48M
Book Value: $3.13
Earnings/Share: $-1.74
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -27.88%
ROE (TTM): -51.93%
Revenue (TTM): $26.87M
Revenue/Share (TTM): $0.37
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 6.93x 0.02x 0.25x N/A -0.03x
2024-12-31 7.32x 0.01x 0.22x N/A -0.02x
2023-12-31 7.16x 0.01x 0.22x N/A -0.01x
2022-12-31 7.98x 0.00x 0.22x -88.27x -0.01x
2021-12-31 7.98x 0.00x 0.23x -1.97x -0.01x
2020-12-31 12.07x 0.00x 0.09x -53.20x -0.01x
2019-12-31 4.62x 0.01x 0.22x -39.14x -0.02x
2018-12-31 4.30x 0.00x 0.21x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ZNTL.US!